• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS SANTA CLARA MYNXGRIP; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS SANTA CLARA MYNXGRIP; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number MX6721
Device Problems Decrease in Pressure (1490); Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/10/2023
Event Type  malfunction  
Manufacturer Narrative
The device is available for analysis but has not yet been received.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, the balloon of two 6/f mynxgrip vascular closure devices (vcd) burst.Both devices failed in the same patient during a diagnostic peripheral procedure.Hemostasis was achieved by manual compression for 30 minutes or less.The burst occurred when pulling the mynx device back, to bring the balloon against the artery.The balloon lost pressure between the first and second stop.There was no reported patient injury.The femoral artery suitability was verified on angiography or venography including the insertion angle of the vascular sheath introducer.The vessel type was arterial.The vessel diameter was verified to be greater than or equal to 5 mm in diameter.There was no vessel tortuosity and no presence of pvd / calcium in the vicinity of the puncture site.The device was stored as per the instructions for use (ifu).There was no prior pta, stent, or vascular graft in the common femoral artery or vein.There was no damage noted in the distal end of the sheath after removal.The deployer is mynx certified.The device is expected to be return for evaluation.
 
Manufacturer Narrative
As reported, the balloon of two 6f/7f mynxgrip vascular closure devices (vcd) burst.Both devices failed in the same patient during a diagnostic peripheral procedure.Hemostasis was achieved by manual compression for 30 minutes or less.The burst occurred when pulling the mynx device back, to bring the balloon against the artery.The balloon lost pressure between the first and second stop.There was no reported patient injury.The femoral artery suitability was verified on angiography or venography including the insertion angle of the vascular sheath introducer.The vessel type was arterial.The vessel diameter was verified to be greater than or equal to 5 mm in diameter.There was no vessel tortuosity and no presence of peripheral vascular disease (pvd) / calcium in the vicinity of the puncture site.The device was stored as per the instructions for use (ifu).There was no prior percutaneous transluminal angioplasty (pta), stent, or vascular graft in the common femoral artery or vein.There was no damage noted in the distal end of the sheath after removal.The deployer was mynx certified.The devices were discarded at site.Five (5) sterile unused mynxgrip 6f/7f devices from lot f2311801 were received for evaluation inside of their original box and sealed packages.During the visual inspection, all the units reviewed were found with no anomalies.Per functional analysis, leak testing was performed on the balloons of the five (5) units selected as a sample and no leak was found.Pressure was maintained with proper functioning of the inflation indicator per the mynxgrip ifu.In addition, after the leak testing, the balloon was able to deflate completely.The reported events of ¿balloon-balloon loss of pressure¿ could not be confirmed as the complaint devices were not returned for analysis.Additionally, the events were not confirmed when testing the sterile devices received since no anomalies were noted.The exact cause of the reported failures experienced by the customer could not be conclusively determined.Based on the information available for review and the product analyses, it is difficult to determine what factors may have contributed to the issues experienced since no issues were found with the balloon of the sterile devices during analysis.However, access site vessel characteristics (although reported to not have pvd/calcium in the vicinity of the puncture site) and/or sheath condition factors are possible since calcification/pvd at the access site or a frayed/damaged sheath tip can cause damage to the balloon, resulting in a loss of pressure.According to the mynxgrip ifu, which is not intended as a mitigation, ¿the safety and effectiveness of the mynxgrip have not been established in the following patient populations: patients with clinically significant peripheral vascular disease in the vicinity of the puncture.¿ also stated in the ifu during product preparation, ¿confirm via femoral arteriogram or venogram: common femoral artery or vein single wall puncture.Evidence of adequate flow.No evidence of significant pvd in the vicinity of the puncture.¿ additionally, users are instructed to discard the device if the balloon does not maintain pressure.Neither the product analyses of the sterile units, nor the information available for review suggest that the reported failures could be related to the design or manufacturing process of the unit.Therefore, no corrective/preventative actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYNXGRIP
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
CORDIS SANTA CLARA
5452 betsy ross drive
santa clara, california 95054
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
5452 betsy ross drive
santa clara, california 95054
7863138372
MDR Report Key18059556
MDR Text Key327212664
Report Number3004939290-2023-03460
Device Sequence Number1
Product Code MGB
UDI-Device Identifier10862028000410
UDI-Public10862028000410
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/02/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMX6721
Device Lot NumberF2311801
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/06/2024
Date Device Manufactured04/28/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-